You are here

ResTORbio

Novartis spinout resTORbio reverse merges with T cell biotech after big PhIII failure

Endpoints

Wed, 04/29/20 - 10:31 am

Parkinson's Disease

ResTORbio stops testing lead drug for respiratory illness; shares crash

Reuters

Fri, 11/15/19 - 11:07 am

clinical trials

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs

Yahoo/Benzinga

Sun, 05/19/19 - 03:59 pm

Bellerophon Therapeutics

Bicycle Therapeutics

Peloton Therapeutics

Nearing phase 3, resTORbio posts new data on infection drug

Fierce Biotech

Tue, 10/16/18 - 09:46 am

respiratory infections

Months after IPO, Novartis spinout resTORbio wins on PhIIb data — stock soars

Endpoints

Wed, 07/25/18 - 10:24 am

Anti-aging startup ResTORbio gets $40M to fuel Phase IIb study

Endpoints

Thu, 11/30/17 - 11:03 am

clinical trials